Roundhill GLP-1 & Weight Loss ETF
OZEM
#2822
ETF rang
€44.48 M
Capitalisation boursière
🇺🇸 US
Marché
26,80 €
Prix de l'action
-1.20%
Changement (1 jour)
44.88%
Changement (1 an)

Roundhill GLP-1 & Weight Loss ETF - Composition

Composition de l'ETF au 9 Avril, 2026Nombre de participations : 29

Liste complète de la composition

Poids %NomSymboleActions détenues
16.25%
Eli Lilly & CoLLY9003
13.09%
Novo Nordisk A/SNVO183834
7.20%
Pfizer IncPFE138419
5.33%
Viking Therapeutics IncVKTX83569
5.23%
Innovent Biologics Inc1801 HK242500
4.80%
Ascletis Pharma Inc1672 HK1133000
3.88%
Roche Holding AGROP SW5146
3.82%
Amgen IncAMGN5762
3.80%
AstraZeneca PLCAZN9819
3.56%
Zealand Pharma A/SZEAL DC40685
3.55%
Hanmi Pharm Co Ltd128940 KS5593
3.48%
Chugai Pharmaceutical Co Ltd4519 JP32800
3.26%
Regeneron Pharmaceuticals IncREGN2218
3.23%
Shanghai Fosun Pharmaceutical Group Co Ltd2196 HK662500
2.92%
CSPC Pharmaceutical Group Ltd1093 HK1298000
2.55%
Structure Therapeutics IncGPCR25378
2.41%
United Laboratories International Holdings Ltd/The3933 HK954000
2.39%
Gubra A/SGUBRA DC22723
2.05%
MBX Biosciences IncMBX34264
1.89%
Gilead Sciences IncGILD7043
1.41%
Shionogi & Co Ltd4507 JP32700
1.37%
Rhythm Pharmaceuticals IncRYTM8463
0.94%
Biohaven LtdBHVN53094
0.69%
First American Government Obligations Fund 12/01/2031FGXXX362037.07
0.51%
Cash & OtherCash&Other268097.43
0.44%
WaVe Life Sciences LtdWVE32778
0.41%
Corbus Pharmaceuticals Holdings IncCRBP22131
0.05%
JAPANESE YENJPY4195210
-0.52%
SWISS FRANCCHF-215321.29